NewLink Genetics | Unleashing Human Potential™ Driven by our relentless commitment to patients with cancer, NewLink Genetics is at the forefront of immuno-oncology with a unique, multifaceted research strategy using HyperAcute® Cellular Immunotherapies and IDO pathway inhibitor technologies.